NCT07639632
Reduce Inefficiencies in Management of Spasticity
Not Yet Recruiting
NAAges 18–80InterventionalDiagnosticThe University of Texas Health Science Center, HoustonInvestigator-initiated
~80 participants
Updated 2026-06-12 on ClinicalTrials.gov
What's tested:ScreenerStandard of care
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Time to detect spasticity from incidence of stroke
Measured over From baseline to 24 months after stroke
Conditions
Where it's being run
1 sites across 1 statesTexas1
Study leadership
- Sean I Savitz, MD · PRINCIPAL_INVESTIGATOR · The University of Texas Health Science Center at Houston PO Box 20036
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Currently admitted for an acute hemorrhagic or ischemic stroke; recurrent stroke allowed if no spasticity at baseline
NIHSS score of \> 0 on items 5 or 6 (required of at least 1 limb)
Willingness to participate in the study for 24 months
Able to sign consent form or availability of a legally authorized representative to sign
Able to read/write in English
Identified MD for follow up post hospitalization
Exclusion
Botulinum toxin use for any indication within the past 12 weeks
Acute life threatening illness
Prior limb injury or neurological diagnosis that limited movement in the now affected limb(s)
Any terminal illness that would limit participation in study follow ups
Known spasticity or other movement disorders that impact tone
What this trial measures
- Time to detect spasticity from incidence of strokeFrom baseline to 24 months after stroke